Dolby Laboratories (DLB) EBT (2009 - 2026)

Dolby Laboratories (DLB) has reported EBT for 18 consecutive years, with $43.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBT fell 21.1% year-over-year to $43.8 million; the trailing twelve-month figure through Jun 2026 stood at $276.8 million (down 13.93% YoY), and the FY2025 full-year result was $303.5 million, down 2.88% from the prior year.
• EBT retreated to $43.8 million in Q2 2026 per DLB's latest filing, from $119.7 million in the prior quarter.
• Across five years, EBT topped out at $121.7 million in Q1 2024 and bottomed at $9.0 million in Q3 2023.
• Historically, EBT has averaged $68.1 million across 5 years, with a median of $57.6 million in 2024.
• The sharpest annual moves came in 2023 and 2024: EBT slumped 70.84% in 2023, then soared 561.29% in 2024.
• Over 5 years, EBT stood at $100.0 million in 2022, then retreated by 19.15% to $80.8 million in 2023, then increased by 6.46% to $86.1 million in 2024, then fell by 16.79% to $71.6 million in 2025, then tumbled by 38.83% to $43.8 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $43.8 million, $119.7 million, and $71.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.